Introduction
Graves' disease (GD) is an autoimmune disease, in which thyroid-receptor antibodies combine with the thyrotropin receptor, promoting the production of thyroid hormones in the follicular cells through stimulation of cyclic adenosine monophosphate. 1 GD is the most common cause of hyperthyroidism. Acceptable therapeutic options are antithyroid drugs (ATDs), radioiodine (RI) therapy, and surgery. 1, 2 The prevalence of therapy varies in different parts of world. ATDs are the first-line therapy in most of the Japanese patients, whereas RI is preferred in the United States. 1 Although the total number of patients in Japan who received RI therapy was much fewer than that in Europe or the United States, 3 the application of RI therapy has extended due to the new regulation that allows its administration in outpatient clinics. 4 Nevertheless, suspicion of malignancy, unwillingness to receive RI therapy, and pregnancy should still be good indications for surgery. Although thyroidectomy has been regarded as a prompt and assured therapy for GD, it has some drawbacks, such as operative scar, need for hospitalization, and complications related to operation, including recurrent laryngeal nerve (RLN) paralysis, hypoparathyroidism, and intraoperative bleeding. 1, 2 Especially in GD, the thyroid gland tends to have hypervascularity, and hemostasis is often difficult. 5, 6 In this study, we evaluated the factors that are relevant to the amount of intraoperative blood loss (AIOBL), and how AIOBL affects postoperative courses retrospectively.
Methods
We reviewed the clinical and laboratory data of 197 consecutive patients with GD, who underwent thyroidectomy between April 2002 and March 2012 at our department. Patients who had undergone neck surgery previously were excluded. GD was defined by the presence of thyrotoxicosis, a diffuse goiter, and a serum thyroid-stimulating hormone receptor antibody or thyroid-stimulating antibody. After the operation, the diagnosis was confirmed histologically in all patients. In preparation for surgery, all patients were given potassium iodide for a median period of 14 days. Operations were performed with conventional open surgery or video-assisted neck surgery. The indications and technique of video-assisted neck surgery were described previously. 7 Subtotal thyroidectomy was defined as leaving between 2 g and 6 g thyroid tissue and near-total thyroidectomy was defined as leaving < 2 g thyroid tissue.
We placed closed suction drainage tubes prior to wound closure in all of the patients except one and removed them 1e3 days later. RLN injury was recorded if voice change was recognized. Calcium supplements and vitamin D analogs were given to those with symptomatic hypocalcemia. Patients who could discontinue the supplements after achieving normocalcemia within 12 months after surgery were identified as those with transient hypocalcemia, whereas patients who had to continue it for more than 12 months and continued to have a below-normal serum intact parathyroid hormone level were categorized as those with permanent hypoparathyroidism.
Clinical variables were assessed in relation to AIOBL. Univariate analysis was performed by single regression analysis to test the correlation between continuous variables and AIOBL, and Student t test was used to compare between groups. A p value of <0.05 was considered statistically significant. For multivariate analysis, the factors identified as being associated with p 0.10 were entered into a stepwise regression analysis to determine the independent risk factors for AIOBL. Statistical analysis was performed with StatMate III for Macintosh (ATMS Co., Ltd, Tokyo, Japan).
Results

Background of patients and operative variables
Background of patients and operative variables are shown in Table 1 . The majority were female (76.1%), with a median age of 34 years. The median period between the onset of the disease and operation was 16 months. The most frequent indication for operation was intolerance to ATDs (41.2%), followed by patient preference (25.4%) and uncontrollable disease (25.4%). Thirty-seven patients (18.8%) needed preoperative adrenocortical hormone administration due to an excessive value of serum-free T4 even after potassium iodide intake. Median intraoperative blood loss was 100 mL (range: 10e1390 mL), and four patients required blood transfusion. Thyroidectomy was performed by open surgery in 125 patients and video-assisted neck surgery in 72 patients. In terms of the extent of resection, 137 subtotal thyroidectomies and 60 near-total/total thyroidectomies were performed. The median weight of thyroid was 45 g (range: 7e480 g). Transient hypocalcemia was seen in 19.8% of the patients, but permanent hypoparathyroidism in only 1.0% of patients. RLN palsy was observed in 3.0% of patients, all of which were temporary. During the study period, we have not experienced hematoma requiring surgical evacuation. Patients were discharged after their operation within a median period of 4 days (range: 2e22 days). Table 2 shows the correlations between clinical variables and AIOBL, as shown by univariate analysis. The strongest correlation of AIOBL was found with the weight of thyroid, with a correlation coefficient of 0.72 (p < 0.0001). Additionally, AIOBL was correlated positively with the period between disease onset and surgery (correlation coefficient 0.36, p < 0.001), and negatively with preoperative free T4 at the initial consultation (correlation coefficient e0.22, p < 0.01). Multivariate analysis revealed that only the weight of the thyroid was correlated with AIOBL (p < 0.0001; Table 3 ). Out of four patients who needed intraoperative blood transfusion (Table 4) , two underwent autotransfusion with preoperatively collected blood.
Factors affecting AIOBL
Impact of intraoperative blood loss on postoperative courses
Although AIOBL was correlated positively with the amount of drainage (correlation coefficient 0.47, p < 0.0001) and the duration of drain retained (correlation coefficient 0.25, p < 0.001), no correlation was seen between AIOBL and postoperative hospital stay (Table 5 ). Furthermore, the occurrence of postoperative morbidity was not correlated with AIOBL.
Discussion
Thyroidectomy for GD has been one of the acceptable therapeutic options, although its prevalence differs from country to country. 1 RI therapy is regarded as a safe and effective therapeutic modality; the majority of patients in the United States are treated with RI therapy, 1,8 which has become a major therapeutic option in Japan as well. Surgery, however, still plays an important role, and thyroidectomy has certain advantages, such as a rapid therapeutic effect, a lower recurrence rate than RI therapy or ATDs, 8e10 and especially no risk of recurrence after the removal of the whole gland. 9 Moreover, when ATDs are intolerable, surgery is the only possible therapeutic modality in patients who are unwilling to receive RI therapy, have Graves' ophthalmopathy, and are pregnant. 1, 2 In the present study, a huge goiter was the only clinical variable that had a positive correlation with AIOBL, as revealed by multivariate analysis. The thyroid gland in a GD patient is rich of vascularity and has dilated vessels around it, and is therefore prone to bleed from the surface or surrounding vessels. 5 Additionally, hemostasis can be difficult due to the huge size of the goiter, difficulty in mobilizing the thyroid, reaching vasculatures, and subsequently cutting off the inflow of blood. We experienced two cases of permanent hypoparathyroidism (1.0%) and no permanent RLN palsy postoperatively, whose rates were comparable to those of previous reports. 2, 9, 11 Because the number of patients with these permanent complications was very small to address statistical evaluation, we evaluated transient complications in this study. Among benign goiter surgeries, GD itself was shown as an independent risk factor for either postoperative transient hypoparathyroidism 12 or RLN palsy. 13 In our study, AIOBL was not related to the complications, and that might be the reason why no correlation was found between AIOBL and postoperative stay.
Continued growth of a Graves' goiter in a patient on ATDs and increasing the difficulty of a delayed thyroidectomy were reported previously. 2 In our analysis, the disease period was correlated positively with the weight of the thyroid and inversely with free T4 levels, according to univariate analysis (data not shown). This implied that the indication for thyroidectomy changed with the course of the disease; for example, although patients with a short term of disease tended to undergo thyroidectomy due to functional issues, those suffering from the disease for a long period of time underwent surgery due to other reasons, such as huge goiter and Graves' ophthalmopathy, even when function was controlled by ATDs. Several randomized trials showed that administration of ATDs for more than 18 months did not improve the remission rate. 14e16 Although Erbil et al 17 showed a negative correlation between ADT treatment duration and AIOBL by multivariate analysis, our result was the opposite, according to univariate analysis, even though most of our patients took ATDs at the time of operation. The reason for this discrepancy was not defined; according to our results, definitive therapy should be considered after a couple of years of ATD therapy, not only from the aspect of remission rate but also the safety on operation.
Four out of 11 cases with thyroids weighing more than 200 g underwent intraoperative blood transfusion (data not shown). We could not evaluate the vascularity, which was reported to affect AIOBL, 17 in all cases because it was a retrospective study. We believe that further prospective examinations may find a notable formula that predicts AIOBL more accurately. Regardless of this limitation, our results recommend that preparation for blood transfusion should be made in GD patients with a huge goiter estimated to weigh more than 200 g. Table 5 Impact of blood loss on perioperative courses. 
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